MedTrace Logo

Positive Predictive Value (PPV) of Pseudomonas Aeruginosa

NCT03290690 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2020-03-06

No results posted yet for this study

Summary

This is a non-randomized, single-blind post market clinical follow-up study for which 65 patients will be imaged at Rouge Valley Centenary Hospital (Scarborough and Rouge Hospital) who present with a chronic wound and are receiving standard wound care treatment. The MolecuLight i:X imaging device will be used by the study clinician as an adjunctive tool in the assessment of the wound and will be used to guide the targeted sampling of a wound (with curettage scraping), as per current standard of care in the principal investigator's wound care clinic. The acquired tissue sample will then be analysed using conventional gold standard semi-quantitative culture methods to determine bacterial species present, also as per current standard of care in this clinic.

Conditions

  • Wound
  • Chronic Leg Ulcer
  • Wound Contamination

Sponsors & Collaborators

  • Scarborough Rouge Hospital

    collaborator OTHER

  • MolecuLight Inc.

    lead INDUSTRY

Principal Investigators

  • Rose Raizman · Scarborough Rouge Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-04
Primary Completion
2020-07-30
Completion
2020-07-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03290690 on ClinicalTrials.gov